Skip to content
Review Open access

NOD-like receptor pyrin domain-containing protein 3 inflammasome activation in microbiota-induced neuroinflammation: Relevance to autism and stress disorders

Jul 2026 · Microbes & Immunity · pp. 026100024 · 0 citations

TL;DR

Novel mechanistic findings that link gut microbiota dysregulation to NLRP3-mediated neuroinflammation are integrated, its involvement in ASD and stress susceptibility is clarified, and treatment approaches targeting microbial modulation and inflammasome suppression are examined.

Abstract

The gut–brain axis has evolved into a bidirectional neuroimmune communication network linking microbial ecology, innate immunity, endocrine signaling, and central nervous system function. The NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome is a key cytosolic sensor that converts signals from microbes into pro-inflammatory pathways. Growing evidence shows that changes in microbial metabolites, intestinal permeability, and systemic immune activation caused by dysbiosis all lead to NLRP3 inflammasome signaling in microglia, astrocytes, and neurons. This neuroinflammatory response mediated by the inflammasome has been progressively associated with the pathophysiology of autism spectrum disorder (ASD) and stress-related neuropsychiatric diseases, such as anxiety and post-traumatic stress disorder. Gut microbial disturbances facilitate peripheral cytokine release, compromise the blood–brain barrier, induce mitochondrial stress, and generate reactive oxygen species—all of which are crucial upstream activators of NLRP3. The development of interleukin (IL)-1β and IL-18, which depends on inflammasomes, worsens synaptic plasticity, neurotransmitter balance, and control of the hypothalamic–pituitary–adrenal axis. In this review, we integrate novel mechanistic findings that link gut microbiota dysregulation to NLRP3-mediated neuroinflammation, clarify its involvement in ASD and stress susceptibility, and examine treatment approaches targeting microbial modulation and inflammasome suppression. Comprehending this immunometabolic axis may facilitate targeted neuroimmune therapies for neurodevelopmental and stress-related diseases.

Read PDF

Similar papers

Review Aug 2026

Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer’s disease: pre-clinical and clinical status of emerging therapeutics

This review breaks down the pathways triggered by immune cells activation (neurotoxic microglial phenotype) and majorly focusing over the NLRP3 inflammasome neuroinflammation pathway, exploring the promising therapeutic potential of specific bioactive phytochemicals, repurposed and novel synthetic drugs/agents to shut-...

Devesh Yaduvanshi, Rishabh Aggarwal, Sameeya A et al. · 0 citations
Review Open access Sep 2026

The NLRP3 inflammasome in physiological and dysfunctional host response in human sepsis and critical illness: a narrative review

Although targeted modulation of inflammasome pathways represents a promising therapeutic strategy, further research is needed to refine patient selection, identify reliable biomarkers, and better characterise disease heterogeneity to enable successful clinical translation.

Caroline Neumann, Florian Hickl, Julia Kemnitzer et al. · 0 citations
Review Open access Aug 2026

Targeting the P2X7–NLRP3 Inflammasome Axis in Obesity: Circadian Regulation of Metabolic Inflammation and Disease Progression

This study signifies the mechanisms underlying circadian regulation of the P2X7–NLRP3 axis, its tissue-specific roles in obesity, and available preclinical and clinical evidence, and further review innovative therapeutics like inflammatory inhibiting targets including inflammasome inhibitors, P2X7 antagonists and chron...

Sudha Jumani Sudha Jumani · 0 citations
Review Open access Sep 2026

The P2X7R-NLRP3 inflammasome axis in Alzheimer’s disease and therapeutic potential of synthetic and plant-derived natural compounds: A review

This review summarizes the progressive molecular events linking Αβ and tau pathology to neuroinflammation via the P2X7R-NLRP3 inflammasome axis, while underscoring the therapeutic potential of plant-derived bioactive compounds as well as synthetic molecules in mitigating the progression of Alzheimer’s disease.

Rishabh Goswami, Nidhi Sharma, V. Jhawat et al. · 0 citations
Review Open access Sep 2026

Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives—A Narrative Review

Atherosclerosis is an age-related immune-metabolic disease in which lipid retention, endothelial dysfunction, innate immune activation, and vascular remodeling interact over decades. In older adults, inflammaging, mitochondrial dysfunction, defective autophagy/mitophagy, and cellular senescence may lower the threshold...

Yelizaveta A. Marakhovskaya, Ksenia A. Eruslanova, O. Maltseva et al. · 0 citations
Review Open access Sep 2026

Crosstalk between innate immune signaling pathways and integrated TLR, NLRP3 inflammasome, cGAS–STING, and NF-κB networks in sepsis

This review comprehensively examines the molecular architecture and dynamic interactions among these signaling networks, highlighting the shared adaptor proteins, regulatory feedback loops, and signaling hubs that determine the transition from protective host defense to uncontrolled hyperinflammation and subsequent imm...

Xiao-Xi Du, Han-Chua Qiao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.